How Health Canada's ‘Draft Guidance on Electronic Media in Prescription Drug Labelling’ May Affect Drug Advertising
Canadian Association of Professionals in Regulatory Affairs (CAPRA)
Health Canada (HC) launched a consultation on the 'DRAFT Guidance for Electronic Media in Prescription Drug Labelling' on March 12, 2021 and will close it to new input on May 7, 2021. The proposed guidance mentions many sections of the Food and Drugs Act & Regulations (FDA&R) related to drug advertising and promotion.